Articles By Anuja Singh
Can USC’s AI Implant Replace Opioids in Chronic Pain Management?
USC and UCLA unveil AI-powered, wireless spinal implant that delivers real-time, adaptive pain relief without drugs, batteries, or…
Can Tampa General’s New AI Ambient Tech Redefine Nurse Workflows and Patient Experience?
AI-powered voice technology by Microsoft brings ambient documentation to frontline nurses, boosting care quality and clinical efficiency Key…
Can Ottai’s New AI Biosensor Reshape Chronic Disease Management for Millions?
AI-powered wearable from Oxford-founded Ottai offers real-time insights, personalized support, and voice-driven healthcare experience Key Takeaways AI-Driven Transformation…
Accelerating Drug Discovery with Artificial Intelligence: Strategic Insights from Pharma’s Biggest AI Alliances
Executive SummaryThe convergence of artificial intelligence (AI) and drug discovery is a strategic imperative. Pharmaceutical giants including Sanofi,…
Is Merck’s WINREVAIR Set to Redefine First-Year PAH Treatment? Phase 3 HYPERION Results Show…
Key Takeaways:• Game-Changing Efficacy: WINREVAIR™ (sotatercept-csrk) cut clinical worsening risk in PAH by a statistically significant margin in…
Can Sanofi’s Sarclisa-VRd Regimen, Backed by EMA’s CHMP, Redefine Frontline Standards in Transplant-Eligible Multiple…
Key Highlights EMA’s CHMP Endorses Sarclisa-VRd for Frontline Multiple Myeloma in Transplant-Eligible AdultsOn June 23, 2025, Sanofi announced…

Can USC’s AI Implant Replace Opioids in Chronic Pain Management?
USC and UCLA unveil AI-powered, wireless spinal implant that delivers real-time, adaptive pain relief without drugs, batteries, or…
Can Tampa General’s New AI Ambient Tech Redefine Nurse Workflows and Patient Experience?
AI-powered voice technology by Microsoft brings ambient documentation to frontline nurses, boosting care quality and clinical efficiency Key…
Can Ottai’s New AI Biosensor Reshape Chronic Disease Management for Millions?
AI-powered wearable from Oxford-founded Ottai offers real-time insights, personalized support, and voice-driven healthcare experience Key Takeaways AI-Driven Transformation…
Accelerating Drug Discovery with Artificial Intelligence: Strategic Insights from Pharma’s Biggest AI Alliances
Executive SummaryThe convergence of artificial intelligence (AI) and drug discovery is a strategic imperative. Pharmaceutical giants including Sanofi,…
Is Merck’s WINREVAIR Set to Redefine First-Year PAH Treatment? Phase 3 HYPERION Results Show…
Key Takeaways:• Game-Changing Efficacy: WINREVAIR™ (sotatercept-csrk) cut clinical worsening risk in PAH by a statistically significant margin in…
Can Sanofi’s Sarclisa-VRd Regimen, Backed by EMA’s CHMP, Redefine Frontline Standards in Transplant-Eligible Multiple…
Key Highlights EMA’s CHMP Endorses Sarclisa-VRd for Frontline Multiple Myeloma in Transplant-Eligible AdultsOn June 23, 2025, Sanofi announced…






